BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32981551
Number of visits today
8148
Number of downloads
16155799
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Ji W, Peng Z, Sun B, Chen L, Zhang Q, Guo M, Su C. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1. Front Oncol 2021;11:678714. [PMID: 34178664 DOI: 10.3389/fonc.2021.678714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Wang X, Ding Y, Hui N, Su B, Yang M. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Eur J Med Res 2022;27:216. [DOI: 10.1186/s40001-022-00854-1] [Reference Citation Analysis]
2 Wang X, Xing Z, Chen H, Yang H, Wang Q, Xing T. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma. Front Oncol 2022;12:953529. [DOI: 10.3389/fonc.2022.953529] [Reference Citation Analysis]
3 Shen L, Gu P, Qiu C, Ding WT, Zhang L, Cao WY, Li ZY, Yan B, Sun X. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway. Ann Hepatol 2022;27:100680. [PMID: 35108614 DOI: 10.1016/j.aohep.2022.100680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345